Silence Therapeutics Share Price (SLN)
| Bid price | 455.00 | Open price | 445.00 |
|---|---|---|---|
| Ask price | 457.00 | Prev close | 455.00 |
| High price | 0.00 | Spread | 0.44% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Silence Therapeutics share prices, Silence Therapeutics stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Silence Therapeutics Level 2 Data, indepth research tools and investor commentary for Silence Therapeutics (SLN) and other London Stock Exchange equities.
Silence Therapeutics Share Price Chart
Register now for FREE Silence Therapeutics share price charts
Silence Therapeutics Share Price Information
| Name | Silence Therapeutics | Epic | SLN |
|---|---|---|---|
| Sector | n/a | ISIN | GB00B9GTXM62 |
| Activites | n/a | Index | n/a |
Silence Therapeutics Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 19/04/2021 | BUY | Mark Rothera | CEO | 18,189 |
| 19/04/2021 | BUY | Michael Davidson | D | 12,993 |
| 19/04/2021 | BUY | Steven Romano | NED | 12,993 |
| 19/04/2021 | BUY | David Lemus | NED | 651 |
| 03/12/2020 | BUY | Mark Rothera | CEO | 3,600 |
Silence Therapeutics Company News
Additional listing and Total Voting Rights
RNS Number : 6284F Silence Therapeutics PLC 17 November 2020 Additional listing and Total Voting Rights November 17, 2020 LONDON, Silence Therapeutics plc,...
Silence Therapeutics presents positive pre-clinical safety data
RNA-focused treatment developer Silence Therapeutics said it had presented positive pre-clinical safety data for its lead product candidate at the American Heart Association virtual Scientific Sessions 2020. The results demonstrated that a potent and sustained reduction of lipoprotein levels in...
Positive pre-clinical data presented
RNS Number : 3489F Silence Therapeutics PLC 16 November 2020 Silence Therapeutics Presents Positive Pre-Clinical Data for SLN360 for the Treatment of Elevated Lipoprotein(a) at American Heart Association 2020...
More Silence Therapeutics Company News >>
Register now for FREE Silence Therapeutics company news
Silence Therapeutics Share Price Discussions
Silence Therapeutics (SLN)
SILENCE THERAPEUTICS plc ("Silence Therapeutics" or "the Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2007 London, UK, 28 September 2007 - Silence Therapeutics plc (London LSE: SLN)...
Register now for FREE Silence Therapeutics share price discussions